globenewswire

FLORHAM PARK, N.J., July 01, 2025 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq: CLRB) (the “Company”), a late-stage clinical biopharmaceutical company focused on the discovery and development of drugs for the treatment of cancer, today announced the pricing of an underwritten public offering for gross proceeds of approximately $6 million prior to deducting underwriting commissions and offering expenses.

OMAHA, Neb., July 01, 2025 (GLOBE NEWSWIRE) -- TeleVox, the industry-leading provider of omnichannel patient relationship management platforms, is addressing the outreach gap in patient care with the launch of the Planned Outreach Program. This new solution, integrated within the award-winning TeleVox Practice Edition platform, is designed to drive patient engagement results for small practices with smart, automated outreach.

Driven by Modular Innovation, Smart Battery Architecture, and Proven Field Performance, Flux Power Accelerates the Shift Toward Intelligent Electrification in Airport Ground Support

SARASOTA, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a company focused on developing unique, intranasal pharmaceuticals for the treatment of neurological disorders, today announced that it has entered into a placement agency agreement for the purchase and sale of up to 800,000 shares of the Company’s Series H Convertible Preferred Stock (“Preferred Stock”), no par value, and Warrants to purchase up to an additional 800,000 shares of Preferred Stock of the Company at an exercise price of $25.00 per share (the “Warrants”). The combined public Offering price of each share of Preferred Stock together with an accompanying Warrant is $25.00 (the “Offering”). The Preferred Stock is convertible into the Company’s common stock, par value $0.001 per share (the “Common Stock”), at a conversion price of $2.50 per share. The closing of the Offering is expected to occur on or about July 2, 2025, subject to the satisfaction of customary closing conditions.

HOUSTON, July 01, 2025 (GLOBE NEWSWIRE) -- Evolution Petroleum Corporation (NYSE American: EPM) ("Evolution" or the "Company") today announced the initial results of its joint interest audit of its Barnett Shale properties and is providing an update on its latest Chaveroo drilling results.

LAS VEGAS, July 01, 2025 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) ("GTV" or the "Company") is pleased to announce the completion of a significant restructuring of its legacy debt obligations and capital structure. The Company has now executed a definitive agreement with a third-party investor who has acquired all outstanding notes previously held by its largest creditor, T&K Zarro, LLC. This strategic investor has expressed strong alignment with the Company's long-term vision and is committed to supporting its continued growth.

As part of the transaction, Golden Triangle Ventures and T&K Zarro, LLC have executed and closed an agreement transferring five outstanding debt instruments—representing more than $7 million in total obligations—to the new private investor. The closing was subject to several corporate actions, including an increase in the Company’s authorized share capital. In connection with the transaction, GTVH secured a fixed price repurchase right from the new investor, granting the Company the exclusive option to reacquire the full balance of the notes, at any time, for a total of $4 million. This represents a significant discount and provides a pathway to eliminate the debt under favorable terms.

New Alliance Aims to Scale Grocery Logistics for SMEs With Real-Time Tracking, IoT Integration, and Regional Economic Impact

OSS to Deliver 61 Rugged Data Storage Units for the P-8A Poseidon Reconnaissance Aircraft

JACKSONVILLE, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers” or the “Company”) (NASDAQ: REG) will announce its second quarter 2025 earnings results on Tuesday, July 29, 2025, after the market closes. The Company’s earnings release and supplemental information package will be posted on the Investor Relations section of the Company’s website – investors.regencycenters.com. The Company will host an earnings conference call on Wednesday, July 30, 2025, at 11:00 a.m. ET.